MainGene successfully IPO in Hong Kong stock market

Main Gene is a genetic testing technology developer, focusing on providing genetic testing services for health management, medical clinical, scientific research and other systems. It has developed products such as early tumor screening and drug sensitivity gene testing. Successful Hong Kong IPO today. The issue price was HK$18, and it opened higher at HK$19.48 on the first day of listing. As of press time, the stock price fell slightly to HK$19, an increase of 5.67%, with a total market value of HK$4.55 billion.

This article is reproduced from:
This site is for inclusion only, and the copyright belongs to the original author.

Leave a Comment

Your email address will not be published.